And since 2001, when he joined Simmons Hanly Conroy as one of just seven attorneys, he has continued that strong foundation-building and teamwork.
Today, he is managing shareholder of the firm, which has 78 attorneys. He has overseen growth in the firm’s pharmaceutical injury, intellectual property and commercial litigation practices.
Becoming an attorney was always his career of choice, Angelides said. After completing his undergraduate work at Kenyon College in Ohio, Angelides attended Saint Louis University School of Law.
He wanted his focus to be on personal injury but didn’t foresee mass tort work so early in his career until he began working on mesothelioma cases with Simmons Hanly Conroy.
“I did not think I would be doing (mass torts) when I first started out, but I’m very glad I did,” he said.
In the past year the firm’s work on mass tort cases has garnered a $7.5 million verdict for a New York welder exposed to asbestos, and millions more in settlements on other cases. They’ve also seen $16 billion in settlements for owners of Volkswagen vehicles in diesel emissions cases, and had three consecutive nine-figure jury verdicts in trials over a hip implant.
Angelides attributes that success to the firm’s investment in its people, technology, and building relationships.
“Those three things are, at least internally, things that we’ve tried to do to foster the culture here and to get those types of results,” he said.
For example, Angelides said, the firm is advancing its technology in all areas of file handling from intake to e-discovery as well as settlement and lien resolution.
“Technology has really helped us internally to become a lot more efficient, and that’s really something that’s going to continue in the future,” Angelides said.
He is also most proud of firm’s contributions to multiple charitable organizations, including the Mesothelioma Applied Research Foundation, the Asbestos Disease Awareness Organization, and Miles for Meso 5K Races.
During Angelides’ tenure as managing shareholder, the firm has expanded its offices with an extended footprint in San Francisco, Los Angeles and New York.
“The growth of our firm outside the St. Louis metropolitan area was something I thought we could achieve, and we have achieved,” he said.
And its next step in growth will be to expand new litigation areas as it has been doing through work in opioid issues.
“The societal impacts of the opioid epidemic are real, and they’re facing communities every day,” Angelides said. “We’re really excited to be leaders in that case and part of that project.”
Correction: A previous version of this story incorrectly listed the number of attorneys currently at Simmons Hanly Conroy. We regret the error.